CLINICAL_TRIALS
trial_result
· 2010-12-06
Clinical Trial Update: Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis [Phase 2]
Summary
A Phase 2 Vienna Challenge Chamber trial evaluating RV658 for seasonal allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Respivert Ltd | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED